Patricia Allen is an experienced professional in the biotechnology industry, currently serving as a Board Member and Audit Committee Chair at Zenas BioPharma since February 2024 and at Anokion since 2016. Allen has held similar roles at Deciphera Pharmaceuticals, SwanBio Therapeutics, Inversago Pharma, and Yumanity Therapeutics. In addition, Allen served as Chief Financial Officer at Vividion Therapeutics, Inc. and Zafgen, Incorporated, contributing to financial leadership in the sector. Allen's expertise includes consulting within the biotech industry from 2011 to 2013. Educational qualifications include a Bachelor of Science in Accounting from Bryant University, obtained between 1980 and 1984.